Inhibition of p38 kinase activity by aryl ureas

1998 
(57) Abstract: The present invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases and proteolytic enzyme mediated diseases other than cancer than cancer, as well as pharmaceutical compositions for use in such treatments for .
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []